Form 8-K - Current report:
SEC Accession No. 0002007919-25-000083
Filing Date
2025-08-13
Accepted
2025-08-13 16:06:24
Documents
14
Period of Report
2025-08-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K inhibrx-20250813.htm   iXBRL 8-K 25740
2 EX-99.1 exhibit99106302025.htm EX-99.1 69906
6 inhibrxlogo.jpg GRAPHIC 36727
  Complete submission text file 0002007919-25-000083.txt   277626

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT inhibrx-20250813.xsd EX-101.SCH 1809
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT inhibrx-20250813_lab.xml EX-101.LAB 23449
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT inhibrx-20250813_pre.xml EX-101.PRE 13596
16 EXTRACTED XBRL INSTANCE DOCUMENT inhibrx-20250813_htm.xml XML 2929
Mailing Address 11025 N. TORREY PINES ROAD, SUITE 140 LA JOLLA CA 92037
Business Address 11025 N. TORREY PINES ROAD, SUITE 140 LA JOLLA CA 92037 (858) 795-4220
Inhibrx Biosciences, Inc. (Filer) CIK: 0002007919 (see all company filings)

EIN.: 990613523 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)